Millennium Management
TENX icon

Millennium Management’s Tenax Therapeutics TENX Stock Holding History

Millennium Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.54M Buy
533,889
+231,416
+77% +$3.13M ﹤0.01% 2330
2025
Q4 		$3.69M Sell
302,473
-11,239
-4% -$97.8K ﹤0.01% 3344
2025
Q3 		$2.39M Buy
313,712
+79,998
+34% +$489K ﹤0.01% 3875
2025
Q2 		$1.36M Buy
233,714
+207,088
+778% +$1.2M ﹤0.01% 4193
2025
Q1 		$174K Sell
26,626
-183
-0.7% -$1.17K ﹤0.01% 5338
2024
Q4 		$166K Buy
+26,809
New +$130K ﹤0.01% 5360
2023
Q3 		– Sell
-207
Closed -$4.97K – 6558
2023
Q2 		$4.97K Buy
+207
New +$5.52K ﹤0.01% 5863
2022
Q4 		– Sell
-49
Closed -$13K – 7049
2022
Q3 		$13K Buy
49
+42
+600% +$16.9K ﹤0.01% 6586
2022
Q2 		$3K Buy
+7
New +$7.01K ﹤0.01% 6830
2018
Q1 		– Sell
-5
Closed -$80K – 4074
2017
Q4 		$80K Hold
5
– – ﹤0.01% 3689
2017
Q3 		$58K Hold
5
– – ﹤0.01% 3398
2017
Q2 		$120K Hold
5
– – ﹤0.01% 3279
2017
Q1 		$91K Buy
+5
New +$182K ﹤0.01% 3336
2015
Q1 		– Sell
-1
Closed -$94K – 4088
2014
Q4 		$94K Buy
+1
New +$121K ﹤0.01% 3777
2014
Q2 		– Sell
-5
Closed -$956K – 3864
2014
Q1 		$956K Buy
+5
New +$990K ﹤0.01% 2253

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management's TENX Position: Q1 2026 in Review

Millennium Management increased its Tenax Therapeutics (TENX) stake by 77% in Q1 2026, buying an estimated $3.13M and bringing the position to 533,889 shares worth $8.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2330.

Millennium Management first reported a position in TENX in Q1 2014 and has held it in 15 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Millennium Management held 533,889 shares of Tenax Therapeutics worth $8.54M as of Q1 2026.
  • Millennium Management bought 231,416 Tenax Therapeutics shares in Q1 2026, an estimated $3.13M.
  • Tenax Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2330 holding.
  • Millennium Management first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 15 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.